Akademisyen
BALA GÜR DEDEOĞLU
PROFESÖR
ANKARA ÜNİVERSİTESİ BİYOTEKNOLOJİ ENSTİTÜSÜ BİYOTEKNOLOJİ ANABİLİM DALI
- Ana Dal Fen Bilimleri ve Matematik Temel Alanı
- Yan Dal Moleküler Biyoloji ve Genetik
Kayıtlı çıktılara kısa bakış — ayrıntılar aşağıda.
- Makale 54
- Proje 0
- Kitap 0
- Bildiri 50
- Patent 0
- Sanatsal 0
Scopus (SJR)
Q1
16
Q2
16
Q3
5
Q4
2
WoS (JCR)
Q1
10
Q2
15
Q3
9
Q4
3
TR Index
8
makale
Alan+yıl+tür normalize OpenAlex yüzdelik — Clarivate ESI / SciVal değildir.
Üst %1 makale
0
Üst %10 makale
5
Ort. yüzdelik
58.9%
Üst %1 payı
0.0%
Üst %10 payı
10.4%
Makaleler
YÖKSİS ve OpenAlex kaynak ayrımıyla makaleler; quartile ve TR Index ile daraltabilirsiniz.
Makale listesi
- 2024 miR-770-5p-induced cellular switch to sensitize trastuzumab resistant breast cancer cells targeting HER2/EGFR/IGF1R bidirectional crosstalk OpenAlex 81.3%
- 2023 The Hidden Footprints of Platelets in IgG4-Related Disease Pathogenesis
- 2022 miRNA-REGULATED PATHWAYS OF CD8+ T CELLS IN TNBC MOUSE MODEL OpenAlex 6.8%
- 2021 Experimental MicroRNA Targeting Validation OpenAlex 88.5%
- 2018 PO-352 The effects of lapatinib responsive miRNA on cell proliferation and cell invasion in HER2 +breast cancer cell line
- 2018 PO-355 Antitumor activity of HSA-miR-X in HER2 positive cells is mediated by the regulation of AKT and ERK
- 2018 PO-194 Identification of regulatory circuits specific to breast cancer development by enrichment based circuit finder
- 2016 The role of hsa-miR-X in cell motility and invasion in triple-negative breast cancer cell lines OpenAlex 10.2%
- 2014 644: miRNA-mRNA integrated analysis in breast cancer: Let-7 cluster as a meta-signature for grade classification OpenAlex 13.9%
- 2013 High-Throughput Approaches for MicroRNA Expression Analysis OpenAlex üst %10 OpenAlex 96.1%
- 2009 Analysis of differentially expressed geExpression of notch signaling pathway recenes in breast cancer : BRCA1- induced gene expression profiles and meta-analysis gene signature
- 2008 Inhibition of focal adhesion kinase with her-2 targeted antibody pertuzumab (Omnitarg®, 2C4) in breast cancer cells OpenAlex 36.7%
- 2007 Lack of association between the MDM2-SNP309 polymorphism and breast cancer risk. OpenAlex üst %10 OpenAlex 90.3%